Interestingly, evidence suggests that the atypical pathways, instead of the IKK2-dependent canonical pathway, are the major contributors to the cytoprotective effects of NF-κB activation on oligodendrocytes in MS and EAE [16,25,140]. The gene discussed is NFKB1; the disease is myeloid sarcoma.